Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AHTC Corp (AHTC)-formerly Advanced Health (ADVH) -- Ignore unavailable to you. Want to Upgrade?

To: Zebra 365 who wrote (351)	1/16/1999 6:46:00 AM
From: Don Earl	Read Replies (1) \| Respond to of 371

Hi Zebra, I was counting the class action as one, the one for $400K that was just settled, the one from the ex partner that wants his patents back, and the one in the announcement today. Class action suits I tend to disregard. Most companies have insurance to protect against share holder suits. I assume the ex partner that wants the patents back doesn't have a leg to stand on. Pretty hard to sign a contract to sell something at an agreed upon price, then come back later and want to change his mind. The one in the news today strikes me as odd in that they took this long to attempt collection, but I assume there were notes and contracts signed that will hold up in court. Although all the law suits are messy, I don't see them as being much of a threat to the company's ability to do business. The float on ADVH is only 2.9 million shares while the short interest is 1.8 million shares. It won't take much for the price to come unglued once the money starts coming in. Regards, Don

To: Zebra 365 who wrote (351)	1/22/1999 9:08:00 PM
From: Zebra 365	Read Replies (1) \| Respond to of 371

SAN FRANCISCO--(BUSINESS WIRE)--Jan. 19, 1999-- The Internet will dramatically change healthcare by enhancing communications, streamlining processes, and creating new business opportunities, says a new research report from Hambrecht & Quist. ''The 'health.net' companies that stand at the confluence of healthcare and the Internet will reap the rewards of progress,'' according to H&Q analysts Stephen M. Fitzgibbons and Richard Lee. The report, ''The health.net Industry,'' analyzes the emerging pure-play health.net companies in three segments: content, community and services; connectivity and communications; and e-commerce. The overwhelming majority of these companies are privately-held, at present. The report details the revenue opportunities for these companies in e-commerce, connectivity and advertising/sponsorship. Of these, e-commerce, estimated to be in the hundreds of billions of dollars, represents the largest and most immediate opportunity. ''The e-commerce companies are pursuing substantial opportunities in both the consumer and business markets,'' say the H&Q analysts. The connectivity market, estimated to be $10+ billion, will be penetrated more gradually. ''The connectivity players, consisting of healthcare information technology and emerging health.net companies, provide solutions to connect the various healthcare participants, including providers, patients, payers and suppliers,'' say the analysts. ''These companies will incrementally deploy Web technology in an effort to rapidly aggregate users on the front- and back-end of transactions. While we believe the opportunity is huge, and the work critical, the progress will come gradually as a number of hurdles need to be cleared.'' Advertising/sponsorship, the third market opportunity identified by analysts Fitzgibbons and Lee, is estimated at hundreds of millions of dollars, ''with huge potential upside.'' In assessing the overall impact of the Internet on healthcare, the authors note that an estimated $250 billion in healthcare spending is wasted on unnecessary or avoidable care, redundant tests, and excessive administrative costs. ''This statistic,'' they add, ''tells only half the story. The intangible costs of poor information flow far outweigh the quantifiable deficiencies. Unlike other industries, in healthcare, good information can mean the difference between life and death.'' The publicly-traded companies mentioned in this report include Cerner (Nasdaq: CERN - news); Eclipsys (Nasdaq: ECLP - news); HBO & Co., now part of McKesson (NYSE: MCK - news); IDX Systems (Nasdaq: IDXC - news); mediconsult.com (Nasdaq: MCNS - news); OnHealth Network Co. (Nasdaq: ONHN - news); Advanced Health (Nasdaq: ADVH - news) and Shared Medical Systems (NYSE: SMS - news). The report is available on Hambrecht & Quist's Web site at www.hamquist.com. Hambrecht & Quist is a leading underwriter of public equity, and a leader in merger and acquisition advisory and private equity services for growth companies in the technology, healthcare, services and branded consumer sectors. H&Q has completed more than 380 equity offerings globally since 1995, raising more than $27 billion for emerging growth companies. H&Q's principal offices are in San Francisco, New York and Boston with additional offices in Europe, Asia and southern California, and a strategic partnership in Israel. Its stock is traded on the NYSE, symbol HQ. -------------------------------------------------------------------------------- Contact: H&Q Corporate Communications Carole Newman, 415/439-3611